# Emergent Technologies

Emergent Technologies is a Private Equity based in Austin, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Austin, United States
- **Region:** North America
- **Address:** 1105 Castle Court, Austin, TX 78703, United States
- **Founded:** 1989
- **Assets under management:** Undisclosed
- **Website:** emergenttechnologies.com
- **LinkedIn:** https://www.linkedin.com/company/emergent-technologies

## Regulatory record

- **Reports private funds:** No

## About

Emergent converts promising ideas and underutilized intellectual property into game-changing, real world solutions. | Headquartered in Austin, Texas, Emergent Technologies, Inc. (Emergent) is a leading innovation solutions company focused on partnering early stage technologies. Emergent utilizes its partner-driven model to identify, manage, develop and bring to market game-changing scientific discoveries.

## Sectors

- Biotech
- Healthcare Services

## People

- Blake Harlan — Author of firm blog post

## Questions

### How does Emergent Technologies source its underlying technologies?

The firm draws from what it describes as trillions of dollars in intellectual capital housed in federal laboratories, universities, and research institutions. Its sourcing model is built on identifying platform technologies with broad commercial potential, then applying an internal methodology to map new applications. This is distinct from a traditional deal-sourcing network focused on founder referrals or auction processes.

### Is Emergent Technologies structured as a venture capital firm or something else?

Emergent Technologies operates more like a technology incubation and commercialization lab than a conventional venture capital firm. Its explicit reference point is Bell Labs, and its process involves hands-on invention, partner involvement, and business formation rather than passive fund commitments. The firm does not publicly market closed-end funds or solicit limited partners.

### Which sectors does Emergent Technologies focus on?

The firm's publicly disclosed activity is concentrated in biotech and healthcare services, specifically targeted biologic therapies. Its known portfolio company, Pure MHC, operates in HLA-based therapeutic target discovery for cancer. Broader sector diversification beyond life sciences is not documented in available sources.

## Related profiles

- [Emergent Medical Partners](https://altss.com/profile/emergent-medical-ventures)
- [Emergent Venture Partners](https://altss.com/profile/emergent-venture-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/emergent-technologies

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology